Annual CFF
$66.23 M
+$60.78 M+1115.01%
December 31, 2023
Summary
- As of February 7, 2025, ATYR annual cash flow from financing activities is $66.23 million, with the most recent change of +$60.78 million (+1115.01%) on December 31, 2023.
- During the last 3 years, ATYR annual CFF has risen by +$50.09 million (+310.27%).
- ATYR annual CFF is now -55.22% below its all-time high of $147.92 million, reached on December 1, 2015.
Performance
ATYR Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFF
-$105.00 K
-$13.51 M-100.78%
September 1, 2024
Summary
- As of February 7, 2025, ATYR quarterly cash flow from financing activities is -$105.00 thousand, with the most recent change of -$13.51 million (-100.78%) on September 1, 2024.
- Over the past year, ATYR quarterly CFF has dropped by -$13.51 million (-100.78%).
- ATYR quarterly CFF is now -100.10% below its all-time high of $104.73 million, reached on June 1, 2015.
Performance
ATYR Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFF
$27.06 M
-$2.79 M-9.34%
September 1, 2024
Summary
- As of February 7, 2025, ATYR TTM cash flow from financing activities is $27.06 million, with the most recent change of -$2.79 million (-9.34%) on September 1, 2024.
- Over the past year, ATYR TTM CFF has dropped by -$2.79 million (-9.34%).
- ATYR TTM CFF is now -81.71% below its all-time high of $147.92 million, reached on December 1, 2015.
Performance
ATYR TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
ATYR Cash From Financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +1115.0% | -100.8% | -9.3% |
| 3 y3 years | +310.3% | -111.4% | +396.4% |
| 5 y5 years | +1662.8% | -111.4% | +396.4% |
ATYR Cash From Financing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -39.8% | +1115.0% | -100.2% | at low | -75.4% | +493.3% |
| 5 y | 5-year | -39.8% | +4857.3% | -100.1% | +94.7% | -75.6% | +1925.4% |
| alltime | all time | -55.2% | +1662.8% | -100.1% | +94.7% | -81.7% | +656.2% |
ATyr Pharma Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$105.00 K(-100.8%) | $27.06 M(-9.3%) |
| Jun 2024 | - | $13.40 M(+73.4%) | $29.85 M(+22.0%) |
| Mar 2024 | - | $7.73 M(+28.1%) | $24.46 M(-63.1%) |
| Dec 2023 | $66.23 M(+1115.0%) | $6.03 M(+125.0%) | $66.23 M(+8.4%) |
| Sep 2023 | - | $2.68 M(-66.6%) | $61.11 M(-0.5%) |
| Jun 2023 | - | $8.02 M(-83.8%) | $61.45 M(+14.9%) |
| Mar 2023 | - | $49.50 M(+5291.7%) | $53.47 M(+880.8%) |
| Dec 2022 | $5.45 M(-95.0%) | - | - |
| Dec 2022 | - | $918.00 K(-69.5%) | $5.45 M(+19.5%) |
| Sep 2022 | - | $3.01 M(+7625.6%) | $4.56 M(-94.7%) |
| Jun 2022 | - | $39.00 K(-97.4%) | $85.42 M(-1.4%) |
| Mar 2022 | - | $1.48 M(+5189.3%) | $86.65 M(-21.2%) |
| Dec 2021 | $110.03 M(+581.6%) | $28.00 K(-100.0%) | $110.03 M(-0.9%) |
| Sep 2021 | - | $83.87 M(+6498.7%) | $111.00 M(+304.2%) |
| Jun 2021 | - | $1.27 M(-94.9%) | $27.46 M(+13.4%) |
| Mar 2021 | - | $24.86 M(+2388.2%) | $24.22 M(+50.0%) |
| Dec 2020 | $16.14 M(+1108.3%) | $999.00 K(+199.1%) | $16.14 M(+22.8%) |
| Sep 2020 | - | $334.00 K(-117.0%) | $13.15 M(+3.6%) |
| Jun 2020 | - | -$1.97 M(-111.7%) | $12.69 M(-32.2%) |
| Mar 2020 | - | $16.78 M(-941.1%) | $18.73 M(+1302.2%) |
| Dec 2019 | $1.34 M | -$2.00 M(+1535.2%) | $1.34 M(-22.2%) |
| Sep 2019 | - | -$122.00 K(-103.0%) | $1.72 M(-1215.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2019 | - | $4.07 M(-757.8%) | -$154.00 K(-96.8%) |
| Mar 2019 | - | -$619.00 K(-61.6%) | -$4.87 M(+14.8%) |
| Dec 2018 | -$4.24 M(-108.0%) | -$1.61 M(-19.1%) | -$4.24 M(-267.0%) |
| Sep 2018 | - | -$1.99 M(+212.1%) | $2.54 M(-94.6%) |
| Jun 2018 | - | -$639.00 K(-8087.5%) | $47.03 M(-10.8%) |
| Mar 2018 | - | $8000.00(-99.8%) | $52.71 M(+0.0%) |
| Dec 2017 | $52.70 M(+1022.1%) | $5.16 M(-87.9%) | $52.70 M(-3.6%) |
| Sep 2017 | - | $42.50 M(+743.3%) | $54.69 M(+382.7%) |
| Jun 2017 | - | $5.04 M(>+9900.0%) | $11.33 M(+105.1%) |
| Mar 2017 | - | $1000.00(-100.0%) | $5.53 M(+17.6%) |
| Dec 2016 | $4.70 M(-96.8%) | $7.15 M(-931.3%) | $4.70 M(-232.3%) |
| Sep 2016 | - | -$860.00 K(+12.4%) | -$3.55 M(+2.2%) |
| Jun 2016 | - | -$765.00 K(-7.5%) | -$3.47 M(-103.4%) |
| Mar 2016 | - | -$827.00 K(-24.6%) | $102.02 M(-31.0%) |
| Dec 2015 | $147.92 M(+5788.4%) | -$1.10 M(+39.9%) | $147.92 M(+0.5%) |
| Sep 2015 | - | -$784.00 K(-100.7%) | $147.23 M(-0.0%) |
| Jun 2015 | - | $104.73 M(+132.4%) | $147.24 M(+209.5%) |
| Mar 2015 | - | $45.07 M(-2625.0%) | $47.57 M(+1793.8%) |
| Dec 2014 | $2.51 M(-95.0%) | -$1.78 M(+130.9%) | $2.51 M(-41.5%) |
| Sep 2014 | - | -$773.00 K(-115.3%) | $4.30 M(-15.2%) |
| Jun 2014 | - | $5.06 M(>+9900.0%) | $5.07 M(>+9900.0%) |
| Mar 2014 | - | $13.00 K | $13.00 K |
| Dec 2013 | $50.74 M | - | - |
FAQ
- What is aTyr Pharma annual cash flow from financing activities?
- What is the all time high annual CFF for aTyr Pharma?
- What is aTyr Pharma annual CFF year-on-year change?
- What is aTyr Pharma quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for aTyr Pharma?
- What is aTyr Pharma quarterly CFF year-on-year change?
- What is aTyr Pharma TTM cash flow from financing activities?
- What is the all time high TTM CFF for aTyr Pharma?
- What is aTyr Pharma TTM CFF year-on-year change?
What is aTyr Pharma annual cash flow from financing activities?
The current annual CFF of ATYR is $66.23 M
What is the all time high annual CFF for aTyr Pharma?
aTyr Pharma all-time high annual cash flow from financing activities is $147.92 M
What is aTyr Pharma annual CFF year-on-year change?
Over the past year, ATYR annual cash flow from financing activities has changed by +$60.78 M (+1115.01%)
What is aTyr Pharma quarterly cash flow from financing activities?
The current quarterly CFF of ATYR is -$105.00 K
What is the all time high quarterly CFF for aTyr Pharma?
aTyr Pharma all-time high quarterly cash flow from financing activities is $104.73 M
What is aTyr Pharma quarterly CFF year-on-year change?
Over the past year, ATYR quarterly cash flow from financing activities has changed by -$13.51 M (-100.78%)
What is aTyr Pharma TTM cash flow from financing activities?
The current TTM CFF of ATYR is $27.06 M
What is the all time high TTM CFF for aTyr Pharma?
aTyr Pharma all-time high TTM cash flow from financing activities is $147.92 M
What is aTyr Pharma TTM CFF year-on-year change?
Over the past year, ATYR TTM cash flow from financing activities has changed by -$2.79 M (-9.34%)